A5102771872- COVID-19 Clinical Research Studies
- Long-Term Effects of COVID-19
- Pneumonia and Respiratory Infections
- SARS-CoV-2 and COVID-19 Research
- Thermal Regulation in Medicine
- Intensive Care Unit Cognitive Disorders
- Drug-Induced Hepatotoxicity and Protection
- Vitamin C and Antioxidants Research
- Curcumin's Biomedical Applications
- Infectious Encephalopathies and Encephalitis
- Antibiotic Resistance in Bacteria
- Family and Patient Care in Intensive Care Units
- Respiratory viral infections research
- Influenza Virus Research Studies
- Nigella sativa pharmacological applications
- Appendicitis Diagnosis and Management
- Bacterial Infections and Vaccines
- Kawasaki Disease and Coronary Complications
- Inhalation and Respiratory Drug Delivery
- COVID-19 Impact on Reproduction
- Hepatitis C virus research
Shiraz University of Medical Sciences
2020-2024
Background Coronavirus disease 2019 (COVID‐19) typically presents with respiratory illness ranging in severity. Neurological complications of the remain largely unknown. Herein, we discuss case a woman diagnosed COVID‐19 meningitis following two positive cerebrospinal fluid (CSF) RT‐PCR assays, and highlight importance recognizing neurological manifestations disease. Case report The patient was 49‐year‐old history hypertension who presented non‐specific symptoms (fever, headache, malaise,...
The combination of sofosbuvir and daclatasvir has shown preliminary efficacy for hospitalized patients with COVID-19 in four open-label studies small sample sizes. This larger trial aimed to assess if the addition sofosbuvir/daclatasvir standard care improved clinical outcomes COVID-19.This was a placebo-controlled, double-blind, randomized adults at 19 hospitals Iran. Patients were oral 400/60 mg once-daily or placebo care. included they had positive PCR diagnostic chest CT, O2 saturation...
Background: In patients with coronavirus disease 2019 (COVID-19), the incidence of delirium has been increased due to nature and specific protective protocols implemented control outbreak this disease. The purpose study was determine effect multidimensional nursing interventions on in COVID-19. Materials Methods: A quasiexperimental (preintervention, postintervention assessment) conducted in168 (84 each group) COVID-19 admitted general wards Hazrat Ali-Asghar Educational Hospital Shiraz ,...
Background: The combination of sofosbuvir (SOF) and daclatasvir (DCV) has shown preliminary efficacy for patients with COVID-19 in five open-label studies small sample sizes. This larger trial aimed to assess if the addition standard care improved clinical endpoints hospitalized moderate or severe COVID-19. Methods: was a placebo-controlled, randomized adults admitted 19 hospitals Iran. Patients were SOF/DCV 400/60mg once-daily placebo care. included they had positive PCR diagnostic chest...
Background: The prior studies showed that nanocurcumin (NC) has potential anti‐viral properties against a wide range of viral infections, making it promising candidate for treating COVID‐19. This study aimed to investigate the effect NC supplementation on acute phase proteins, including interleukin‐6 (IL‐6), C‐reactive protein (CRP), albumin (ALB) and Erythrocyte Sedimentation Rate (ESR), biochemical markers lactate dehydrogenase (LDH), aspartate aminotransferase (AST), alanine transaminase...
Background: Despite remarkable developments in medical science, viral infections still remain serious threats to the global health system. Methods: In this cross-sectional study, we retrospectively compared clinical, serological, and radiological findings subjects with confirmed A-H1N1, B- H1N1, or A-H3N2 virus infection. The investigation included data on influenza patients who were admitted Al-Zahra Hospital, Isfahan, Iran, from September 2017 February 2018. Results Conclusions: Based...
Multisystemic Inflammatory Syndrome in Children (MIS-C) has emerged as a challenging entity during the COVID-19 era. Here, we present first case of MIS-C comprised acute appendicitis and myocarditis Iran. Unfortunately, diagnosis was made late, patient died following an appendectomy extensive fluid therapy.
Introduction: Ventilator-associated pneumonia (VAP) is a complicated condition that usually occurs two-three days after endo-tracheal intubation and characterized by some signs symptoms such as fever, changed white blood cell count chest infiltration. Objectives: Our study was aimed at comparing the therapeutic effects of meropenem, injectable colistin plus nebulized colistin, G-CSF (granulocyte-colony stimulating factor) in patients with VAP result multidrug-resistance Acinetobacter....